Anuradha Sajjanhar does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
BENGALURU, June 28 (Reuters) - India is planning to offer incentives to promote local manufacturing of GLP-1 drugs used to treat diabetes and obesity, in 2026, a top government official said on Friday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback